Faster access than browser!
16 relations: Breast cancer, Cancer, Chemotherapy, Cyclic guanosine monophosphate–adenosine monophosphate, Drug development, HER2/neu, Metastasis, Neoplasm, New Zealand, Non-small-cell lung carcinoma, Novartis, Phases of clinical research, Prostate cancer, Stimulator of interferon genes, University of Auckland, Vascular-targeting agent.
Breast cancer
Breast cancer is cancer that develops from breast tissue.
New!!: Vadimezan and Breast cancer · See more »
Cancer
Cancer is a group of diseases involving abnormal cell growth with the potential to invade or spread to other parts of the body.
New!!: Vadimezan and Cancer · See more »
Chemotherapy
Chemotherapy (often abbreviated to chemo and sometimes CTX or CTx) is a type of cancer treatment that uses one or more anti-cancer drugs (chemotherapeutic agents) as part of a standardized chemotherapy regimen.
New!!: Vadimezan and Chemotherapy · See more »
Cyclic guanosine monophosphate–adenosine monophosphate
Cyclic guanosine monophosphate–adenosine monophosphate (cyclic GMP-AMP, cGAMP) is the first cyclic di-nucleotide found in metazoa.
New!!: Vadimezan and Cyclic guanosine monophosphate–adenosine monophosphate · See more »
Drug development
Drug development is the process of bringing a new pharmaceutical drug to the market once a lead compound has been identified through the process of drug discovery.
New!!: Vadimezan and Drug development · See more »
HER2/neu
Receptor tyrosine-protein kinase erbB-2, also known as CD340 (cluster of differentiation 340), proto-oncogene Neu, Erbb2 (rodent), or ERBB2 (human), is a protein that in humans is encoded by the ERBB2 gene.
New!!: Vadimezan and HER2/neu · See more »
Metastasis
Metastasis is a pathogenic agent's spread from an initial or primary site to a different or secondary site within the host's body; it is typically spoken of as such spread by a cancerous tumor.
New!!: Vadimezan and Metastasis · See more »
Neoplasm
Neoplasia is a type of abnormal and excessive growth of tissue.
New!!: Vadimezan and Neoplasm · See more »
New Zealand
New Zealand (Aotearoa) is a sovereign island country in the southwestern Pacific Ocean.
New!!: Vadimezan and New Zealand · See more »
Non-small-cell lung carcinoma
Non-small-cell lung carcinoma (NSCLC) is any type of epithelial lung cancer other than small cell lung carcinoma (SCLC).
New!!: Vadimezan and Non-small-cell lung carcinoma · See more »
Novartis
Novartis International AG is a Swiss multinational pharmaceutical company based in Basel, Switzerland.
New!!: Vadimezan and Novartis · See more »
Phases of clinical research
The phases of clinical research are the steps in which scientists do experiments with a health intervention in an attempt to find enough evidence for a process which would be useful as a medical treatment.
New!!: Vadimezan and Phases of clinical research · See more »
Prostate cancer
Prostate cancer is the development of cancer in the prostate, a gland in the male reproductive system.
New!!: Vadimezan and Prostate cancer · See more »
Stimulator of interferon genes
Stimulator of interferon genes (STING), also known as transmembrane protein 173 (TMEM173) and MPYS/MITA/ERIS is a protein that in humans is encoded by the TMEM173 gene.
New!!: Vadimezan and Stimulator of interferon genes · See more »
University of Auckland
The University of Auckland (Te Whare Wānanga o Tāmaki Makaurau) is the largest university in New Zealand, located in the country's largest city, Auckland.
New!!: Vadimezan and University of Auckland · See more »
Vascular-targeting agent
A vascular-targeting agent (VTA) or vascular disrupting agent (VDA) is a drug designed to damage the vasculature (blood vessels) of cancer tumors causing central necrosis.
New!!: Vadimezan and Vascular-targeting agent · See more »
